Palvella Therapeutics (PVLA) Assets Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.90% |
| Dec 31, 2025 | -10.72% |
| Sep 30, 2025 | -10.37% |
| Jun 30, 2025 | -8.94% |
| Mar 31, 2025 | -8.49% |
| Dec 31, 2024 | -8.96% |
| Sep 30, 2024 | -29.37% |
| Jun 30, 2024 | -28.15% |
| Mar 31, 2024 | -25.79% |
| Dec 31, 2023 | -44.34% |
| Sep 30, 2023 | -17.10% |
| Jun 30, 2023 | -11.58% |
| Mar 31, 2023 | -13.84% |
| Dec 31, 2022 | -1.67% |
| Sep 30, 2022 | 0.06% |
| Jun 30, 2022 | 1.53% |
| Mar 31, 2022 | 17.25% |
| Dec 31, 2021 | 34.36% |
| Sep 30, 2021 | 30.30% |
| Jun 30, 2021 | 27.26% |
| Mar 31, 2021 | 25.49% |
| Dec 31, 2020 | 25.34% |
| Sep 30, 2020 | 26.17% |
| Jun 30, 2020 | 52.08% |
| Mar 31, 2020 | 49.14% |
| Dec 31, 2019 | 45.21% |
| Sep 30, 2019 | 1,296.26% |
| Jun 30, 2019 | 551.61% |
| Mar 31, 2019 | 1,362.29% |
| Dec 31, 2018 | 80.99% |
| Jun 30, 2018 | 691.98% |